RecruitingNCT07464886
N-acetylcysteine and mindfulness therapy for mild depression in young people
About this title
Read the official source — NCT07464886Medication studyAges 15–24United States
Understand this study
Who could participate?
Listed age limits: 15 years to 24 years.
- Listed locations
- CincinnatiSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 26, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 160
- Sponsor
- University of Cincinnati
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 15 Years to 24 Years
- Official registry ID
- NCT07464886
- Official title
Show the full official title
Prefrontal Glutamatergic Modulation by N-acetylcysteine and Mindfulness-based Cognitive Therapy for Mild Depression in Youth
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Cincinnati
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Cincinnati, a university.
Does this study involve medication?
Yes. The study involves medication, including N-acetylcysteine and Placebo.
Who can participate?
Listed age limits: 15 years to 24 years.
Is this study still recruiting?
The registry lists this study as recruiting.
